This panel presentation features executives from three different companies that are looking to advance innovations in healthcare, each of them with ongoing or planned Phase 3 trials here. We’ve titled the panel, Phase 3 Drugs to Watch.

Hosted by Lytham Partners Managing Partner Robert Blum, and featuring industry executives Laxminarayan Bhat, Ph.D., Founder & CEO of Reviva Pharmaceuticals (RVPH), Prashant Kohli, CEO of Acasti Pharma Inc. (ASCT), and Quang P., CEO of Cadrenal Therapeutics, Inc. (CVKD), we explore companies at the vanguard of clinical trials.

This KOL Panel was recorded at the Lytham Partners Spring 2023 Investor Conference.